<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
RIGL
Rigel Pharmaceuticals
$
()


  • Rigel Pharmaceuticals' olutasidenib shows efficacy in published AML study

    4/4/2024 - 08:11am
  • Rigel Pharmaceuticals names Lisa Rojkjaer, M.D. as Chief Medical Officer

    3/12/2024 - 08:08am
  • Rigel Pharmaceuticals price target raised by $1 at Citi, here's why

    3/7/2024 - 07:07am
  • Rigel Pharmaceuticals reports Q4 EPS 0c, consensus (3c)

    3/5/2024 - 16:04pm
  • Rigel Pharmaceuticals price target raised by 50c at B. Riley, here's why

    2/26/2024 - 08:25am
  • Rigel Pharmaceuticals acquires U.S. rights to Gavreto

    2/22/2024 - 07:54am
  • Rigel Pharmaceuticals sees Q4 revenue $35.7M, consensus $29.78M

    1/8/2024 - 08:07am
  • Rigel Pharmaceuticals collaborating with Connect network in Phase 2 glioma trial

    1/4/2024 - 08:10am
  • Biotech Alert: Searches spiking for these stocks today

    12/11/2023 - 11:06am
  • Rigel Pharmaceuticals, MD Anderson partner to evaluate REZLIDHIA in AML

    12/8/2023 - 08:07am
  • Biotech Alert: Searches spiking for these stocks today

    11/24/2023 - 10:34am
  • Rigel Pharmaceuticals price target lowered to $1.25 from $1.75 at B. Riley

    11/9/2023 - 09:04am
  • Rigel Pharmaceuticals reports Q3 EPS (3c), consensus (7c)

    11/7/2023 - 16:05pm
  • Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call

    10/26/2023 - 13:45pm
  • Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call

    10/26/2023 - 04:55am
dynamic_feed Breaking News